Simsek Mehmet, Sadik Salih, Taskin Omur, Guler Hayrettin, Onoglu Ahmet, Akar Munire, Kursun Sinan, Tinar Sivekar
Department of Obstetrics and Gynecology, Akdeniz University School of Medicine, Antalya and SSK Tepecik, Izmir, Turkey.
J Minim Invasive Gynecol. 2006 Jul-Aug;13(4):315-9. doi: 10.1016/j.jmig.2006.03.004.
The aim of this study was to evaluate the efficacy of laparoscopic uterine artery coagulation (LUC) in symptomatic myomatous patients.
Prospective study (Canadian Task Force classification II).
Tertiary care center
Twenty-one women with myomatous uteri.
Laparoscopic uterine artery coagulation.
Laparoscopic uterine artery coagulation for myoma was performed by three-puncture laparoscopy, and the difference in uterine and/or myoma volume was determined every 3 months for 12 months clinically and using ultrasonographic and MRI calculations of uterine volume. In addition, pre and postprocedure uterine Doppler indices were determined. Main outcome measures were symptomatic improvement after LUC and reduction in volume calculated by ultrasonography and magnetic resonance imaging (MRI). All treated women reported less bleeding after treatment. At 12 months, a 57% reduction in bleeding was seen in these patients. The mean postoperative pictorial blood loss assessment was significantly lower at 12 months: 303 +/- 30.4 mL (95% CI 284-328) baseline versus 173.5 +/- 17.8 mL (95% CI 164-184) after treatment, p < .05. Postoperative pain was documented in all the patients with a visual analog scale, with a mean of 1.6 cm recorded. The mean reduction in uterine volume (pre- to post-LUC) was 195 +/- 24.3 cm3 (range 89-438). The mean operating time was 52.1 +/- 7.2 minutes (95% CI 49.8-55.4), and the mean estimated blood loss was 65.2 +/- 11.8 dL (95% CI 59.6-70.8). Mean hospitalization time was 32.3 +/- 6.6 hours (95% CI 29.2-35.4). The complication rates were low with the procedure (fever, infection). No patient required hysterectomy due to complications. Ninety percent of the women were satisfied with the procedure.
Laparoscopic uterine artery coagulation is effective in the management of symptomatic myomas, reducing bleeding and the volume of both uterus and myomas as documented by ultrasonography and MRI. Laparoscopic uterine artery coagulation is a cost-effective and low-morbidity option compared with conventional approaches such as myomectomy or hysterectomy. If the patient's predominant complaint is the feeling of a mass and/or bleeding, alternative treatment options should be explored. The results of this study are encouraging, but more research is needed to validate the cost-effectiveness and long-term results.
本研究旨在评估腹腔镜子宫动脉凝固术(LUC)对有症状子宫肌瘤患者的疗效。
前瞻性研究(加拿大工作组分类II级)。
三级医疗中心
21名患有子宫肌瘤的女性。
腹腔镜子宫动脉凝固术。
通过三孔腹腔镜对肌瘤进行腹腔镜子宫动脉凝固术,在12个月内每3个月通过临床检查以及使用超声和MRI计算子宫体积来确定子宫和/或肌瘤体积的差异。此外,还测定了术前和术后的子宫多普勒指数。主要结局指标为LUC术后症状改善情况以及超声和磁共振成像(MRI)计算的体积缩小情况。所有接受治疗的女性均报告治疗后出血减少。在12个月时,这些患者的出血减少了57%。术后12个月时,平均术后图像失血评估值显著降低:基线时为303±30.4 mL(95%CI 284 - 328),治疗后为173.5±17.8 mL(95%CI 164 - 184),p <.05。所有患者均使用视觉模拟量表记录术后疼痛,平均记录为1.6 cm。子宫体积(LUC术前至术后)平均减少195±24.3 cm³(范围89 - 438)。平均手术时间为52.1±7.2分钟(95%CI 49.8 - 55.4),平均估计失血量为65.2±11.8 dL(95%CI 59.6 - 70.8)。平均住院时间为32.3±6.6小时(95%CI 29.2 - 35.4)。该手术的并发症发生率较低(发热、感染)。没有患者因并发症需要进行子宫切除术。90%的女性对该手术满意。
腹腔镜子宫动脉凝固术在治疗有症状肌瘤方面有效,可减少出血以及超声和MRI记录的子宫和肌瘤体积。与肌瘤切除术或子宫切除术等传统方法相比,腹腔镜子宫动脉凝固术是一种具有成本效益且发病率低的选择。如果患者的主要诉求是肿块感和/或出血,则应探索其他治疗选择。本研究结果令人鼓舞,但需要更多研究来验证其成本效益和长期结果。